Emotional processes in binge drinking: A systematic review and perspective.

Alcohol Binge drinking Emotional identification Emotional response

Journal

Clinical psychology review
ISSN: 1873-7811
Titre abrégé: Clin Psychol Rev
Pays: United States
ID NLM: 8111117

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 09 06 2020
revised: 10 12 2020
accepted: 08 01 2021
medline: 27 1 2021
pubmed: 27 1 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

Binge drinking is a widespread alcohol consumption pattern commonly engaged by youth. Here, we present the first systematic review of emotional processes in relation to binge drinking. Capitalizing on a theoretical model describing three emotional processing steps (emotional appraisal/identification, emotional response, emotional regulation) and following PRISMA guidelines, we considered all identified human studies exploring emotional abilities among binge drinkers. A literature search was conducted in PubMed, Scopus, and PsychINFO, and a standardized methodological quality assessment was performed for each study. The main findings offered by the 43 studies included are: 1) regarding emotional appraisal/identification, binge drinking is related to heightened negative emotional states, including greater severity of depressive and anxiety symptoms, and have difficulties in recognizing emotional cues expressed by others; 2) regarding emotional response, binge drinkers exhibit diminished emotional response compared with non-binge drinkers; 3) regarding emotional regulation, no experimental data currently support impaired emotion regulation in binge drinking. Variability in the identification and measurement of binge drinking habits across studies limits conclusions. Nevertheless, current findings establish the relevance of emotional processes in binge drinking and set the stage for new research perspectives to identify the nature and extent of emotional impairments in the onset and maintenance of excessive alcohol use.

Identifiants

pubmed: 33497920
pii: S0272-7358(21)00014-3
doi: 10.1016/j.cpr.2021.101971
pmc: PMC8275688
mid: NIHMS1666167
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101971

Subventions

Organisme : NIAAA NIH HHS
ID : U01 AA017347
Pays : United States
Organisme : NIAAA NIH HHS
ID : R37 AA010723
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA021697
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA017347
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA017923
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA017923
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021697
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA010723
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

J Cogn Neurosci. 2011 Sep;23(9):2123-34
pubmed: 20809855
Alcohol. 2018 Nov;72:61-73
pubmed: 30220589
Drug Alcohol Depend. 2020 Apr 1;209:107888
pubmed: 32078974
Subst Use Misuse. 2020;55(2):218-229
pubmed: 31535586
Alcohol. 2020 Feb;82:91-101
pubmed: 31520685
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Psychol Addict Behav. 2018 May;32(3):338-349
pubmed: 29771561
Health Place. 2016 Jan;37:43-9
pubmed: 26706310
Drug Alcohol Depend. 2018 May 1;186:113-119
pubmed: 29567625
PLoS One. 2019 Dec 17;14(12):e0225609
pubmed: 31846468
Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):127-37
pubmed: 18291294
J Psychiatry Neurosci. 2009 Mar;34(2):111-8
pubmed: 19270761
BMC Public Health. 2014 Apr 16;14:366
pubmed: 24735570
Sci Rep. 2017 Oct 31;7(1):14392
pubmed: 29089582
Compr Psychiatry. 2018 May;83:59-63
pubmed: 29587205
Alcohol. 2016 Mar;51:79-87
pubmed: 26992704
Neuron. 2007 Aug 16;55(4):545-55
pubmed: 17698008
Subst Use Misuse. 2018 Nov 10;53(13):2199-2209
pubmed: 29708456
Drug Alcohol Rev. 2016 Mar;35(2):170-6
pubmed: 26094994
Alcohol Clin Exp Res. 2005 Mar;29(3):317-25
pubmed: 15770105
Alcohol Alcohol. 2014 Mar-Apr;49(2):182-6
pubmed: 24169114
Drug Alcohol Depend. 2015 Nov 1;156:1-13
pubmed: 26371405
Neuropharmacology. 2013 Apr;67:521-31
pubmed: 23287538
J Youth Adolesc. 2015 Jan;44(1):1-17
pubmed: 24682958
J Abnorm Psychol. 2013 Aug;122(3):756-69
pubmed: 24016014
Alcohol Clin Exp Res. 2013 Aug;37(8):1432-9
pubmed: 23550712
Alcohol Clin Exp Res. 2017 Dec;41(12):2197-2206
pubmed: 28992398
J Am Geriatr Soc. 2019 Oct;67(10):2139-2144
pubmed: 31364159
Addict Behav. 2019 Sep;96:148-155
pubmed: 31096093
Psychopharmacology (Berl). 2009 Sep;205(4):577-87
pubmed: 19468716
Front Psychol. 2017 Oct 18;8:1795
pubmed: 29093690
Alcohol Clin Exp Res. 2017 Aug;41(8):1432-1443
pubmed: 28618018
Cortex. 2013 Apr;49(4):1155-9
pubmed: 23380042
Int Rev Psychiatry. 2017 Jun;29(3):293-307
pubmed: 28540750
Neurosci Biobehav Rev. 2020 Jun;113:492-506
pubmed: 32298710
Nat Rev Neurosci. 2011 Oct 20;12(11):652-69
pubmed: 22011681
Neuropsychol Rev. 2019 Sep;29(3):357-385
pubmed: 31512192
Alcohol Clin Exp Res. 2010 Mar 1;34(3):396-403
pubmed: 20028366
Biol Psychiatry. 2003 Sep 1;54(5):515-28
pubmed: 12946880
Psychol Addict Behav. 2015 Sep;29(3):673-82
pubmed: 25915691
Brain Behav. 2019 Jun;9(6):e01282
pubmed: 30993908
Trends Cogn Sci. 2018 Apr;22(4):280-293
pubmed: 29571664
Alcohol Clin Exp Res. 2011 Jan;35(1):140-55
pubmed: 21039636
Addict Behav. 2013 May;38(5):2180-6
pubmed: 23454875
Neurosci Biobehav Rev. 2020 Jan;108:400-422
pubmed: 31614153
Am J Prev Med. 2017 Jun;52(6):717-727
pubmed: 28526355
Alcohol Clin Exp Res. 2017 May;41(5):976-986
pubmed: 28340502
J Affect Disord. 2017 Aug 1;217:163-173
pubmed: 28411505
Biol Psychiatry. 2003 Sep 1;54(5):504-14
pubmed: 12946879
J Addict Dis. 2018 Jan-Jun;37(1-2):77-86
pubmed: 30634895
Am J Psychiatry. 2016 Apr 1;173(4):344-61
pubmed: 26771738
Eur J Neurosci. 2007 Jan;25(2):541-50
pubmed: 17284196
Addiction. 2010 Apr;105(4):655-65
pubmed: 20403018
Eur J Neurosci. 2019 Aug;50(3):2297-2310
pubmed: 30099805
Clin Psychol Rev. 2005 Nov;25(7):841-61
pubmed: 16095785
Horm Behav. 2011 Apr;59(4):465-72
pubmed: 21272586
Addiction. 2011 May;106(5):906-14
pubmed: 21382111
Addiction. 2012 Nov;107(11):1939-46
pubmed: 22632107
Trends Cogn Sci. 2017 Dec;21(12):940-949
pubmed: 29150000
J Am Acad Child Adolesc Psychiatry. 2010 Dec;49(12):1189-201; quiz 1285
pubmed: 21093769
Psychol Bull. 2009 Jan;135(1):142-56
pubmed: 19210057
Alcohol Alcohol. 2014 Mar-Apr;49(2):165-72
pubmed: 24217956
Eur J Pharmacol. 2015 Apr 15;753:73-87
pubmed: 25583178
Neuropsychology. 2019 Sep;33(6):781-794
pubmed: 31448946
Neurosci Biobehav Rev. 2017 Sep;80:488-515
pubmed: 28698082
Clin Psychol Rev. 2017 Nov;57:141-163
pubmed: 28941927
Alcohol Clin Exp Res. 2017 Nov;41(11):1970-1979
pubmed: 28902418
Int J Environ Res Public Health. 2019 Nov 18;16(22):
pubmed: 31752082
Addict Behav. 2005 Feb;30(2):203-18
pubmed: 15621393
Nat Neurosci. 2005 Dec;8(12):1704-11
pubmed: 16286932
Neurotoxicol Teratol. 2007 Jan-Feb;29(1):153-63
pubmed: 17196788
Neuropsychol Rev. 2016 Dec;26(4):420-431
pubmed: 27447979
Alcohol Clin Exp Res. 2008 Mar;32(3):414-26
pubmed: 18302724
Alcohol Clin Exp Res. 2015 Dec;39(12):2471-9
pubmed: 26613633
Alcohol Clin Exp Res. 2019 Sep;43(9):1978-1985
pubmed: 31329296
Neuroimage Clin. 2013 Aug 29;3:218-25
pubmed: 24179866
Neuropsychology. 2019 Sep;33(6):808-821
pubmed: 31448948
Addiction. 2017 Jan;112(1):40-48
pubmed: 27287050
Pharmacol Biochem Behav. 2009 Sep;93(3):354-62
pubmed: 19497334
Addict Behav. 2004 Jan;29(1):159-79
pubmed: 14667427
Pharmacol Biochem Behav. 2004 Jul;78(3):611-9
pubmed: 15251270
Alcohol Clin Exp Res. 2008 Jun;32(6):1096-104
pubmed: 18445111
Int Rev Psychiatry. 2020 Feb;32(1):1-2
pubmed: 31916509
Psychol Aging. 2017 Sep;32(6):543-556
pubmed: 28891668
J Am Acad Child Adolesc Psychiatry. 2018 Aug;57(8):550-560
pubmed: 30071976
Neuroimage. 2006 May 15;31(1):397-409
pubmed: 16414281
Trends Cogn Sci. 2017 May;21(5):357-371
pubmed: 28363681
Biol Psychiatry. 2005 Sep 1;58(5):392-400
pubmed: 16018978
Addict Behav. 2013 Apr;38(4):1898-904
pubmed: 23380495
J Evid Based Med. 2015 Feb;8(1):2-10
pubmed: 25594108
Curr Biol. 2011 Oct 25;21(20):1766-70
pubmed: 22000109
Eur Addict Res. 2018;24(3):118-127
pubmed: 29969784
J Drug Educ. 2015;45(3-4):133-55
pubmed: 27075608

Auteurs

Séverine Lannoy (S)

Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, California, USA; Louvain Experimental Psychopathology research group (LEP), Psychological Sciences Research Institute, UCLouvain, Louvain-la-Neuve, Belgium. Electronic address: severine.lannoy.phd@gmail.com.

Theodora Duka (T)

Behavioral and Clinical Neuroscience, School of Psychology, University of Sussex, Brighton, UK; Sussex Addiction and Intervention Centre, University of Sussex, Brighton, UK.

Carina Carbia (C)

APC Microbiome Ireland, Biosciences Building, University College Cork, Cork, Ireland.

Joël Billieux (J)

Institute of Psychology, University of Lausanne, Lausanne, Switzerland.

Sullivan Fontesse (S)

Louvain Experimental Psychopathology research group (LEP), Psychological Sciences Research Institute, UCLouvain, Louvain-la-Neuve, Belgium.

Valérie Dormal (V)

Louvain Experimental Psychopathology research group (LEP), Psychological Sciences Research Institute, UCLouvain, Louvain-la-Neuve, Belgium.

Fabien Gierski (F)

Cognition Health and Society Laboratory (EA 6291), Université de Reims Champagne-Ardenne, Reims, France; Psychiatry and Addictology Departments, CHU de Reims & EPSM Marne, Reims, France.

Eduardo López-Caneda (E)

Psychological Neuroscience Laboratory, Research Center in Psychology (CIPsi), School of Psychology, University of Minho, Campus, Gualtar, Braga, Portugal.

Edith V Sullivan (EV)

Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, California, USA.

Pierre Maurage (P)

Louvain Experimental Psychopathology research group (LEP), Psychological Sciences Research Institute, UCLouvain, Louvain-la-Neuve, Belgium. Electronic address: pierre.maurage@uclouvain.be.

Classifications MeSH